Todd Foley, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 88,716 shares at $20.23 ($1.8M) on 2020-06-02, disclosed to the SEC on 2020-06-03.
Open-market sale of $1.8M RYTM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.08 | 10,535 | $212K | 11.8% |
| 2 | $20.08 | 10,535 | $212K | 11.8% |
| 3 | $20.23 | 15,578 | $315K | 17.6% |
| 4 | $20.23 | 15,578 | $315K | 17.6% |
| 5 | $20.27 | 18,245 | $370K | 20.6% |
| 6 | $20.27 | 18,245 |
| $370K |
| 20.6% |
| Total | $20.21 avg | 88,716 | $1.8M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |